RPL17 and neoplasm: In the A20 lymphoma murine model we treated mice growing tumors with dual checkpoint blockade (DCBA, anti-PD-1 and anti-CTLA-4)—priming polyclonal anti-tumor T cells in vivo—and then transferred their cells into tumor bearing recipients following lymphodepletion(8).